(Q39173050)

9 September 2017

DNA methyltransferases 1 and 3B are required for hepatitis C virus infection in cell culture (English)

1 reference

9 September 2017

1 reference

Chao Chen

1

1 reference

9 September 2017

Dan Pan

2

1 reference

9 September 2017

A-Mei Deng

3

1 reference

9 September 2017

Fang Huang

4

1 reference

9 September 2017

Bin-Lian Sun

5

1 reference

9 September 2017

Rong-Ge Yang

6

1 reference

9 September 2017

language of work or name

English

0 references

publication date

29 March 2013

1 reference

9 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

9 September 2017

441

1 reference

9 September 2017

1

1 reference

9 September 2017

57-65

1 reference

Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b.

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

DNA methyltransferases 1 and 3b expression in Huh-7 cells expressing HCV core protein of different genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

The DNA methyltransferases of mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

5-azacytidine and 5-azadeoxycytidine inhibit human immunodeficiency virus type 1 replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

(-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

5-Azacytidine can induce lethal mutagenesis in human immunodeficiency virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

The history of cancer epigenetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Virus-host interactions in hepatitis C virus infection: implications for molecular pathogenesis and antiviral strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

DNA methylation as a therapeutic target in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

The epigenomics of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Structure and function of mammalian DNA methyltransferases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Cell culture and infection system for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Epigenetic silencing of interferon-inducible genes is implicated in interferon resistance of hepatitis C virus replicon-harboring cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

New insights into structure and replication of the hepatitis C virus and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Epigenetic modifications and human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Increased protein expression of DNA methyltransferase (DNMT) 1 is significantly correlated with the malignant potential and poor prognosis of human hepatocellular carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Hepatitis C virus (HCV) NS2 protein up-regulates HCV IRES-dependent translation and down-regulates NS5B RdRp activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Global epidemiology of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

Targeting DNA methylation for epigenetic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.03.005

10.1016/J.VIROL.2013.03.005

7 January 2021

Identifiers

DOI

1 reference

9 September 2017

1 reference